Wetzel Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$999K Sell
3,933
-157
-4% -$36.6K 0.35% 49
2026
Q1
$1,000K Sell
4,090
-121
-3% -$28.2K 0.4% 44
2025
Q4
$871K Buy
4,211
+24
+0.6% +$4.75K 0.35% 45
2025
Q3
$776K Hold
4,187
0.33% 46
2025
Q2
$640K Sell
4,187
-122
-3% -$18.8K 0.29% 58
2025
Q1
$715K Sell
4,309
-139
-3% -$21.7K 0.36% 48
2024
Q4
$643K Sell
4,448
-67
-1% -$10.4K 0.32% 58
2024
Q3
$732K Buy
4,515
+193
+4% +$30.8K 0.37% 50
2024
Q2
$684K Hold
4,322
0.39% 47
2024
Q1
$630K Buy
4,322
+381
+10% +$60.6K 0.37% 45
2023
Q4
$618K Buy
+3,941
New +$604K 0.38% 44

Other funds holding JNJ

Wetzel Investment Advisors's JNJ Position: Q2 2026 in Review

Wetzel Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q2 2026, selling an estimated $36.6K and leaving 3,933 shares worth $999K. The position accounts for 0.35% of the portfolio, ranked #49.

Wetzel Investment Advisors first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $1,000K in Q1 2026. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Wetzel Investment Advisors held 3,933 shares of Johnson & Johnson worth $999K as of Q2 2026.
  • Wetzel Investment Advisors sold 157 Johnson & Johnson shares in Q2 2026, an estimated $36.6K.
  • Johnson & Johnson made up 0.35% of Wetzel Investment Advisors's portfolio in Q2 2026, its #49 holding.
  • Wetzel Investment Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Wetzel Investment Advisors's Johnson & Johnson position peaked at $1,000K in Q1 2026.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Wetzel Investment Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.